Dr. Timothy Y. Tseng, MD

Dr. Tseng practices at UT Health Medical Arts and Research Center in San Antonio, Texas.

Dr. Tseng's NPI, 1790951333, was assigned on May 4, 2008. Dr. Tseng graduated from Duke University School Of Medicine in 2003. Dr. Tseng holds Texas license N6728.

Dr. Tseng's primary practice is UT Health Medical Arts and Research Center, at 8300 Floyd Curl Dr, San Antonio, TX 78229 in Bexar County. The practice phone is (210) 450-9030.

Dr. Tseng's primary practice is UT Health Medical Arts and Research Center in San Antonio, Texas. Dr. Tseng is also affiliated with University Hospital. The medical group on file is UT Health Physicians. Dmand AI also links Dr. Tseng to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tseng practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Tseng's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Tseng is board certified in urology by the American Board of Urology. Dmand AI has Dr. Tseng's licenses on file in 3 states: Texas, California and North Carolina.

Dmand AI lists enlarged prostate, enlarged prostate transurethral surgery (TURP), kidney cysts, kidney removal surgery, kidney stone disease, urinary endoscopy, urine flow blockage and UTI among the conditions Dr. Tseng treats.

CMS data shows 394 Medicare services from Dr. Tseng across 10 procedure codes in 2024, for 275 Medicare patients. Medicare paid $62,485 for them.

CMS counts 275 Medicare patients who saw Dr. Tseng in 2024. The largest group is 65 to 74, with 117 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tseng's median patient age at 67, with 46% women.

In 2024, Dr. Tseng wrote 352 Medicare Part D claims for 134 patients. 89% of them were for generic drugs. CMS names the drug for 273 of them, across 7 drugs with 11 or more claims each, at $33,025 in total drug cost. In 2023, CMS named 206 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Tseng for performance year 2024, reported through an alternative payment model (APM). Dr. Tseng accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tseng as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 17 papers to Dr. Tseng, published from 2006 to 2023. 2006 was the busiest year, with 2. The most frequent topics are Prostatectomy, Kidney Calculi and Prostatic Neoplasms. Dr. Tseng has published most often in J Urol. Dr. Tseng's most frequent co-authors are Johannes W. Vieweg, MD, Quinton Victor Cancel, MD and Marshall L. Stoller, MD.

CMS Open Payments shows 15 general payments to Dr. Tseng from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 62% of the total. Boston Scientific Corporation paid the most, $1,109.

Dmand AI lists 1 award for Dr. Tseng, most recently CMS Stage 1 EHR in 2013.

Dr. Tseng graduated from Duke University School Of Medicine in 2003.

Dr. Tseng is in network with 22 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.